tiprankstipranks
Inmune Bio Inc (INMB)
NASDAQ:INMB

Inmune Bio (INMB) Cash flow

268 Followers

Inmune Bio Cash Flow

INMB's free cash flow for Q4 2023 was $-3.40M. For the 2023 fiscal year, INMB's free cash flow was decreased by $10.71M and operating cash flow was $-3.40M. See a summary of the company’s cash flow.
Cash Flow
TTM
Dec 23Dec 22Dec 21Dec 20Dec 19
Operating Cash Flow
$ -11.98M$ -11.98M$ -22.69M$ -28.50M$ -8.94M$ -5.38M
Investing Cash Flow
---$ -15.00M$ 0.00-
Financing Cash Flow
$ -4.22M$ -4.22M$ 729.00K$ 96.36M$ 23.89M$ 12.21M
Cash Flow From Discontinued Operation
------
Other Cash Adjustment Inside Changein Cash
------
End Cash Position
$ 175.04M$ 35.85M$ 52.15M$ 74.81M$ 21.97M$ 7.00M
Income Tax Paid Supplemental Data
----$ 0.00$ 0.00
Interest Paid Supplemental Data
$ 1.78M$ 1.78M$ 1.37M$ 559.00K$ 0.00$ 0.00
Issuance Of Capital Stock
$ 775.00K$ 775.00K$ 699.00K$ 80.25M$ 24.91M$ 12.21M
Issuance Of Debt
$ -5.00M$ -5.00M-$ 14.95M$ 0.00-
Repayment Of Debt
$ -5.00M$ -5.00M----
Free Cash Flow
$ -11.98M$ -11.98M$ -22.69M$ -43.50M$ -8.94M$ -5.38M
Domestic Sales
------
Foreign Sales
------
Currency in USD

Inmune Bio Cash Flow

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis